Bladder cancer: open trials in Spain

60 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-05
NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Trial Treatment · Phase 1 · Pfizer
Fundació Puigvert, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-05
NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala d'Oncologia - L'Hospitalet, Barcelona · South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC, Madrid · Hospital Universitario 12 de Octubre, Madrid · Fundacion MD Anderson International Espana, Madrid · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Catalan Institute of Oncology Duran i Reynals Hospital, Barcelona · Hospital Madrid Norte Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen del Rocio, Seville
Registry updated 2026-11-04
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Trial Treatment · Phase 2 · Jazz Pharmaceuticals
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Insular Gran Canarias, Las Palmas · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Regional Universitario de Malaga - Hospital General, Málaga · Complejo Hospitalario de Navarra, Pamplona · INCLIVA-Hospital Clínico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Instituto Oncologico Dr. Rosell S.L. | Oncologia, Barcelona · Hospital Universitari Vall D Hebron | Oncologia Medica, Barcelona · Institut Catala D'oncologia | Hospitalet | Oncologia, L'Hospitalet de Llobregat · Clinica Universidad De Navarra | Madrid | Oncologia, Madrid · Hospital Universitario Fundacion Jimenez Diaz | Oncologia Medica, Madrid
Registry updated 2026-11-04
NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hosp. Univ. de La Ribera, Alzira · Fund. Puigvert, Barcelona · Hosp Univ Vall D Hebron, Barcelona · Hosp Clinic de Barcelona, Barcelona · Hosp. Puerta Del Mar, Cadiz · Hosp. Gral. Univ. de Castellon, Castillón · Hosp. de Jerez de La Frontera, Jerez de la Frontera · Hosp Univ A Coruna, La Coruña (A Coruña) · Hosp. Gral. Univ. Gregorio Maranon, Madrid · Clinica Univ. de Navarra, Madrid · Hosp. Univ. 12 de Octubre, Madrid · Hosp Virgen de La Victoria, Málaga · Hosp. Univ. Central de Asturias, Oviedo · Hosp.Univ.Parc Tauli, Sabadell · Hosp. Virgen Del Rocio, Seville · Hosp. Clinico Univ. de Valencia, Valencia
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Complexo Hospitalario Universitario A Coruña, A Coruña · Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer, Barcelona · Hospital Universitario Puerta del Mar, Cadiz · Hospital General Universitario De Castellon, Castello De La Plana · Area Sanitaria De Ferrol, Ferrol · Hospital de Jerez de la Frontera, Jerez de la Frontera · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-11-03
NCT07416123
A Study of GEN1106 in Participants With Solid Tumors
Trial Treatment · Phase 1 · Genmab
Hospital HM Nou Delfos, Barcelona · START Madrid / Hospital Universitario Fundacion Jimenez Diaz, Madrid · Hospital Universitario Quirónsalud Madrid, Madrid · START Madrid / Centro Integral Oncologico Clara Campal, Madrid
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-03
NCT07265947
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Trial Treatment · Phase 2 · Tyra Biosciences, Inc
Hospital Universitario Puerta del Mar, Cadiz · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-02
NCT07475806
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Trial Treatment · Phase 2 · Astellas Pharma Global Development, Inc.
Granada · Ourense · Pamplona
Registry updated 2026-11-02
NCT06510374
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Ferring Pharmaceuticals
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Fundación Alcorcón, Alcorcón · Hospital del Mar, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario La Paz, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-30
NCT06545955
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Ferring Pharmaceuticals
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Fundación Alcorcón, Alcorcón · Hospital del Mar, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Reina Sofia, Córdoba · MD Anderson Cancer Center, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-30
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
Hospital Universitario de Badajoz, Badajoz · Hospital Quirónsalud Barcelona, Barcelona · Hospital del Mar, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Institut Català d'Oncologia, Girona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario Regional de Málaga, Málaga · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Virgen De Valme, Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-29
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga
Registry updated 2026-10-29
NCT07566156
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Trial Treatment · Phase 3 · Astellas Pharma Global Development, Inc.
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Lucus Augusti, Lugo · Hospital Universitario Ramón y Cajal, Madrid · Hospital Clínico San Carlos, Madrid · Complejo Hospitalario Universitario de Ourense, Ourense · Hospital Universitario Central De Asturias, Oviedo · University Hospital Virgen Del Rocio S.L., Sevilla · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-10-28
NCT06995677
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Tyra Biosciences, Inc
Hospital del Mar, Barcelona · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Clínico San Carlos, Madrid · Hospital Universitario 12 de Octubre, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga · Hospital Universitario Virgen Macarena, Seville · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-10-26
2024-518348-19-00
A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
Trial Treatment · Phase 1 · Novartis Pharma AG
Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid
Registry updated 2026-10-21
NCT07186842
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Trial Treatment · Phase 1/2 · BioNTech SE
Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro, Logroño · Hospital Universitario HM Sanchinarro - START Madrid CIOCC, Madrid · Hospital Universitario Quironsalud Madrid - NEXT Oncology, Pozuelo de Alarcón
Registry updated 2026-10-15
NCT06960577
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
Trial Treatment · Phase 2 · AstraZeneca
Hospital Clinic de Barcelona, Barcelona · Hospital del Mar, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Vall d'Hebron Institute of Oncology, Barcelona · Institut Català d'Oncologia, Girona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Universitario Lucus Augusti, Lugo · Hospital Clínico San Carlos, Madrid · MD Anderson Cancer Center, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-10-08
NCT07421700
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Trial Treatment · Phase 1/2 · Pfizer
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Parc de Salut Mar - Hospital del Mar, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario Virgen del Rocio, Seville
Registry updated 2026-10-08
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Infanta Cristina, Badajoz · Institut Catala d'Oncologia (ICO)-Badalona, Badalona · OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital General Universitario de Elche, Elche · Institut Català d'Oncologia (ICO) - Girona, Girona · Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet · Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital La Princesa, Madrid · Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · MD Anderson Cancer Center, Madrid · H.R.U Málaga - Hospital General, Málaga · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitari Sant Joan de Reus, Reus · Hospital Universitario Marqués de Valdecilla, Santander · CHUS - Hospital Clinico Universitario, Santiago de Compostela · Hospital Universitario Virgen del Rocio, Seville · Hospital Arnau de Vilanova, Valencia
Registry updated 2026-10-07

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error